William P. Keane is Director at SALIX PHARMACEUTICALS LTD (SLXP). They have made 3 open-market trades across 1 company since 2007, most recently 2015-04-01.
CIK 0001204286
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $27K since 2008, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SLXP | 39,160 | — |
Shares reported on the most recent Form 4, priced at the 2015-03-13 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SLXP | SELL · 10b5-1 | 2014-01-07 | 2014-01-09 | $88.31 | $2.0M | N/A | N/A | N/A |
| SLXP | SELL · 10b5-1 | 2013-04-15 | 2013-04-17 | $49.44 | $1.5M | N/A | N/A | N/A |
| SLXP | SELL | 2012-06-05 | 2012-06-07 | $51.67 | $517K | N/A | N/A | N/A |
| SLXP | BUY | 2008-05-09 | 2008-05-12 | $6.68 | $27K | N/A | N/A | N/A |
| SLXP | SELL | 2007-07-03 | 2007-07-06 | $12.30 | $43K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.